Literature DB >> 33676536

Lung clearance index and diffusion capacity for CO to detect early functional pulmonary impairment in children with rheumatic diseases.

Julia Hildebrandt1, Anja Rahn1, Anja Kessler1, Fabian Speth1, Dagmar-Christiane Fischer1, Manfred Ballmann2.   

Abstract

BACKGROUND: In adults with rheumatic diseases pulmonary complications are relevant contributors to morbidity and mortality. In these patients diffusion capacity for CO (DLCO) is an established method to detect early pulmonary impairment. Pilot studies using DLCO indicate that early functional pulmonary impairment is present even in children with rheumatic disease albeit not detectable by spirometry and without clinical signs of pulmonary disease. Since the lung clearance index (LCI) is also a non-invasive, feasible and established method to detect early functional pulmonary impairment especially in children and because it requires less cooperation (tidal breathing), we compared LCI versus DLCO (forced breathing and breath-holding manoeuvre) in children with rheumatic diseases.
FINDINGS: Nineteen patients (age 9-17 years) with rheumatic disease and no clinical signs of pulmonary disease successfully completed LCI and DLCO during annual check-up. In 2 patients LCI and DLCO were within physiological limits. By contrast, elevated LCI combined with physiological results for DLCO were seen in 8 patients and in 9 patients both, the LCI and DLCO indicate early functional pulmonary changes. Overall, LCI was more sensitive than DLCO to detect early functional pulmonary impairment (p = 0.0128).
CONCLUSIONS: Our findings suggest that early functional pulmonary impairment is already present in children with rheumatic diseases. LCI is a very feasible and non-invasive alternative for detection of early functional pulmonary impairment in children. It is more sensitive and less cooperation dependent than DLCO. Therefore, we suggest to integrate LCI in routine follow-up of rheumatic diseases in children.

Entities:  

Keywords:  Children; Diffusion capacity for carbon monoxide; Immunosuppressive therapy; Juvenile idiopathic arthritis; Lung clearance index; Pulmonary impairment; Rheumatic disease

Year:  2021        PMID: 33676536     DOI: 10.1186/s12969-021-00509-1

Source DB:  PubMed          Journal:  Pediatr Rheumatol Online J        ISSN: 1546-0096            Impact factor:   3.054


  2 in total

1.  Lung function in children with juvenile idiopathic arthritis: A cross-sectional analysis.

Authors:  Marina Attanasi; Marta Lucantoni; Daniele Rapino; Marianna I Petrosino; Manuela Marsili; Giorgia Gasparroni; Paola Di Filippo; Sabrina Di Pillo; Francesco Chiarelli; Luciana Breda
Journal:  Pediatr Pulmonol       Date:  2019-05-17

2.  Lung function and diffusing capacity for carbon monoxide in patients with juvenile chronic arthritis: effect of disease activity and low dose methotrexate therapy.

Authors:  A Pelucchi; C Lomater; V Gerloni; A Foresi; F Fantini; L Marazzini
Journal:  Clin Exp Rheumatol       Date:  1994 Nov-Dec       Impact factor: 4.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.